JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
Cytokines are involved in intestinal homeostasis and pathological processes associated
with inflammatory bowel disease (IBD). The biological effects of cytokines, including several …
with inflammatory bowel disease (IBD). The biological effects of cytokines, including several …
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair
loss ranging from patches on the scalp to complete hair loss involving the entire body …
loss ranging from patches on the scalp to complete hair loss involving the entire body …
Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165
ST Wrobleski, R Moslin, S Lin, Y Zhang… - Journal of Medicinal …, 2019 - ACS Publications
Small molecule JAK inhibitors have emerged as a major therapeutic advancement in
treating autoimmune diseases. The discovery of isoform selective JAK inhibitors that …
treating autoimmune diseases. The discovery of isoform selective JAK inhibitors that …
STING controls nociception via type I interferon signalling in sensory neurons
The innate immune regulator STING is a critical sensor of self-and pathogen-derived DNA.
DNA sensing by STING leads to the induction of type-I interferons (IFN-I) and other …
DNA sensing by STING leads to the induction of type-I interferons (IFN-I) and other …
Vitiligo: mechanisms of pathogenesis and treatment
ML Frisoli, K Essien, JE Harris - Annual review of immunology, 2020 - annualreviews.org
Vitiligo is an autoimmune disease of the skin that targets pigment-producing melanocytes
and results in patches of depigmentation that are visible as white spots. Recent research …
and results in patches of depigmentation that are visible as white spots. Recent research …
[HTML][HTML] A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia …
B King, E Guttman-Yassky, E Peeva, A Banerjee… - Journal of the American …, 2021 - Elsevier
Background Alopecia areata (AA) is an autoimmune form of hair loss with limited treatments.
Objective To evaluate the efficacy and safety of the Janus kinase inhibitors ritlecitinib and …
Objective To evaluate the efficacy and safety of the Janus kinase inhibitors ritlecitinib and …
MONN: a multi-objective neural network for predicting compound-protein interactions and affinities
Computational approaches for understanding compound-protein interactions (CPIs) can
greatly facilitate drug development. Recently, a number of deep-learning-based methods …
greatly facilitate drug development. Recently, a number of deep-learning-based methods …
Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention
GW Sewell, A Kaser - Journal of Crohn's and Colitis, 2022 - academic.oup.com
Abstract The interleukin-23 [IL-23] cytokine, derived predominantly from macrophages and
dendritic cells in response to microbial stimulation, has emerged as a critical promoter of …
dendritic cells in response to microbial stimulation, has emerged as a critical promoter of …
[HTML][HTML] Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
Plaque psoriasis is a common, chronic, systemic, immune-mediated inflammatory disease.
The Janus kinase-signal transducer and activator of transcription pathway plays a major role …
The Janus kinase-signal transducer and activator of transcription pathway plays a major role …
[HTML][HTML] Oral ritlecitinib and brepocitinib for moderate-to-severe ulcerative colitis: results from a randomized, phase 2b study
Background & Aims The efficacy and safety of ritlecitinib (oral JAK3/TEC family kinase
inhibitor) and brepocitinib (oral TYK2/JAK1 inhibitor) as induction therapy were assessed in …
inhibitor) and brepocitinib (oral TYK2/JAK1 inhibitor) as induction therapy were assessed in …